Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
104
datasets available to search
ShareScore release 0.9.0
Dataset results
104 results for “ESO”
A Trial of ChAdOx1 and MVA Vaccines Against MAGE-A3 and NY-ESO-1
ClinicalTrials.gov study NCT04908111. IPD Sharing: YES. Countries: 1. Publications: 0.
Study of IMF-001 in Patients With Malignancies Expressing NY-ESO-1
ClinicalTrials.gov study NCT01234012. IPD Sharing: Not stated. Countries: 1. Publications: 0.
NY-ESO-1 Specific T Cells After Cyclophosphamide in Treating Patients With Advanced Synovial Sarcoma or Myxoid/Round Cell Liposarcoma
ClinicalTrials.gov study NCT02059850. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Multi-center Study of TBI-1301 (INN: Mipetresgene Autoleucel; Mip-cel) in Patients With NY-ESO-1 Positive Synovial Sarcoma
ClinicalTrials.gov study NCT07174427. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Clinical Study to Evaluate the Safety and Efficacy of ESO-T01 in Treating Relapsed/Refractory Multiple Myeloma.
ClinicalTrials.gov study NCT06691685. IPD Sharing: NO. Countries: 1. Publications: 0.
Study to Evaluate Safety and Antitumor Activity of Lete-Cel (GSK3377794) in HLA-A2+ Participants With NY-ESO-1 Positive Previously Treated Advanced (Metastatic or Unresectable) Synovial Sarcoma or Myx
ClinicalTrials.gov study NCT06703346. IPD Sharing: NO. Countries: 7. Publications: 0.
A Phase I Study of WT1 or NY-ESO-1 Vaccine and Nivolumab For Recurrent Ovarian Cancer
ClinicalTrials.gov study NCT02737787. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A2-ESO-1 TCR-Engineered T Cells for Relapsed/Refractory Advanced or Metastatic NY-ESO-1 Overexpression Positive Triple Negative Breast Cancer
ClinicalTrials.gov study NCT05989828. IPD Sharing: Not stated. Countries: 1. Publications: 0.
HLA-A*02:01 Allele Frequency and the NY-ESO-1 Expression Status in Cancer Patients in Taiwan
ClinicalTrials.gov study NCT06665776. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Phase 2 Study of MPDL3280A Combined With CDX-1401 in NY-ESO 1 (+) IIIB, IV or Recurrent Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT02495636. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Genetically Engineered Cells (NY-ESO-1 TCR Engineered T Cells and HSCs) After Melphalan Conditioning Regimen in Treating Patients With Recurrent or Refractory Ovarian, Fallopian Tube, or Primary Perit
ClinicalTrials.gov study NCT03691376. IPD Sharing: Not stated. Countries: 1. Publications: 0.
NY-ESO-1 TCR-T Cells for NY-ESO-1 Positive Subjects With Advanced Solid Tumors
ClinicalTrials.gov study NCT05881525. IPD Sharing: NO. Countries: 1. Publications: 0.
Phase 1 Study of Intradermal LV305 in Patients With Locally Advanced, Relapsed or Metastatic Cancer Expressing NY-ESO-1
ClinicalTrials.gov study NCT02122861. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Enhancing Detection of Small Esophageal Varices by PillCam ESO
ClinicalTrials.gov study NCT00911131. IPD Sharing: Not stated. Countries: 0. Publications: 13.
Anti-NY-ESO-1 TCR-Gene Engineered Lymphocytes Given by Infusion to Patients With NY-ESO-1 -Expressing Metastatic Cancers
ClinicalTrials.gov study NCT05296564. IPD Sharing: NO. Countries: 1. Publications: 0.
Phase I/II Trial of Cord Blood-Derived NK Cells Genetically Engineered With NY-ESO-1 TCR/IL-15 Cell Receptor for Relapsed/Refractory Multiple Myeloma
ClinicalTrials.gov study NCT06066359. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of TBI-1301 (NY-ESO-1 T Cell Receptor Gene Transduced Autologous T Lymphocytes) in Patients with Synovial Sarcoma
ClinicalTrials.gov study NCT03250325. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
A Phase 1 Trial of NY-ESO-1 With GLA-SE in Patients With Unresectable or Metastatic Cancer
ClinicalTrials.gov study NCT02015416. IPD Sharing: NO. Countries: 1. Publications: 0.
Randomized, Double Blind, Placebo-controlled Topical Resiquimod Adjuvant for NY-ESO-1 Protein Vaccination
ClinicalTrials.gov study NCT00821652. IPD Sharing: Not stated. Countries: 1. Publications: 0.
T Cell Receptor-transduced T Cells Targeting NY-ESO-1 for Treatment of Patients With NY-ESO-1- Expressing Malignancies
ClinicalTrials.gov study NCT02457650. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.